The pediatric neurology device market valued for $2,764.90 million in 2021 and is projected to reach $5,842.62 million by 2031, registering a CAGR of 7.8% from 2022 to 2031.
Pediatric neurology is a specialized branch of medicine that is known to deal with management and diagnosis of neurological conditions in newborns, infants, children, and adolescents. The discipline of pediatric neurology encompasses disorders and diseases of the brain, spinal cord, autonomic nervous system (ANS), peripheral nervous system (PNS), blood vessels, and muscles that affect a child's nervous system. Most common conditions that pediatric neurologists deal with vary from cerebral palsy or migraines to rare and more complex conditions such as neurodegenerative disorders. In addition, a huge number of patients treated in pediatric neurology have learning difficulties, developmental problems, and epilepsy.
The growth of the pediatric neurology device market is driven by surge in incidence of neurological diseases, prevalence of epilepsy and migraines in children and rise in number of advanced product launches. Moreover, large medical technology firms all over the world are increasingly focusing on acquiring companies that provide devices for neurological disease, which is expected to notably contribute toward the market growth. For instance, in July 2022, France-based investment firm ArchiMed has completed the acquisition of US-based neurodiagnostic devices provider Natus Medical for a total consideration of $1.2 billion. Furthermore, the global pediatric neurology device market growth is largely driven by factors such as increase in significant applications of neurological devices in pediatric patients, various initiatives & funding from government & private bodies for large-scale pediatric neurological diseases study projects and decline in cost of treatment. Prominent players in the global pediatric neurology device market have opted various Strategies such as product launches, acquisition, and investments in R&D for advancement in pediatric neurology device to strengthen their position in the market and sustain the competitive environment.
However, the high cost of neurological disease treatment restricts the market growth. Conversely, various technological advancements such as the development of new and advanced devices for neurological disease treatment and increase in the patient admission in the hospitals are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of biotechnology and medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.
The pediatric neurology device market is segmented based on product, age group, condition, end user and region. On the basis of product, the market is categorized into neurostimulator devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid (CSF) management devices and others. On the basis of age group, the market is classified into 0-1 year, 1-5 years, 5-10 years, above 10 years. On the basis of condition, the market is classified into stroke, seizures, hydrocephalus, oncology and others. On the basis of end user, the market is classified into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings KARL STORZ SE & Co. KG., LivaNova PLC, Medtronic plc, Natus Medical Incorporated (ArchiMed), Stryker Corporation, Zimmer Biomet.
Pediatric neurology is a specialized branch of medicine that is known to deal with management and diagnosis of neurological conditions in newborns, infants, children, and adolescents. The discipline of pediatric neurology encompasses disorders and diseases of the brain, spinal cord, autonomic nervous system (ANS), peripheral nervous system (PNS), blood vessels, and muscles that affect a child's nervous system. Most common conditions that pediatric neurologists deal with vary from cerebral palsy or migraines to rare and more complex conditions such as neurodegenerative disorders. In addition, a huge number of patients treated in pediatric neurology have learning difficulties, developmental problems, and epilepsy.
The growth of the pediatric neurology device market is driven by surge in incidence of neurological diseases, prevalence of epilepsy and migraines in children and rise in number of advanced product launches. Moreover, large medical technology firms all over the world are increasingly focusing on acquiring companies that provide devices for neurological disease, which is expected to notably contribute toward the market growth. For instance, in July 2022, France-based investment firm ArchiMed has completed the acquisition of US-based neurodiagnostic devices provider Natus Medical for a total consideration of $1.2 billion. Furthermore, the global pediatric neurology device market growth is largely driven by factors such as increase in significant applications of neurological devices in pediatric patients, various initiatives & funding from government & private bodies for large-scale pediatric neurological diseases study projects and decline in cost of treatment. Prominent players in the global pediatric neurology device market have opted various Strategies such as product launches, acquisition, and investments in R&D for advancement in pediatric neurology device to strengthen their position in the market and sustain the competitive environment.
However, the high cost of neurological disease treatment restricts the market growth. Conversely, various technological advancements such as the development of new and advanced devices for neurological disease treatment and increase in the patient admission in the hospitals are expected to provide lucrative opportunities for the growth of the market in near future. Extensive R&D activities in the field of biotechnology and medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.
The pediatric neurology device market is segmented based on product, age group, condition, end user and region. On the basis of product, the market is categorized into neurostimulator devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid (CSF) management devices and others. On the basis of age group, the market is classified into 0-1 year, 1-5 years, 5-10 years, above 10 years. On the basis of condition, the market is classified into stroke, seizures, hydrocephalus, oncology and others. On the basis of end user, the market is classified into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings KARL STORZ SE & Co. KG., LivaNova PLC, Medtronic plc, Natus Medical Incorporated (ArchiMed), Stryker Corporation, Zimmer Biomet.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pediatric neurology device market analysis from 2021 to 2031 to identify the prevailing pediatric neurology device market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the pediatric neurology device market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global pediatric neurology device market trends, key players, market segments, application areas, and market growth Strategies.
Key Market Segments
By Product Type
- Neurostimulation Devices
- Neurosurgery Devices
- Interventional Neurology Devices
- Cerebrospinal Fluid Management Devices
By Condition
- Stroke
- Seizures
- Hydrocephalus
- Oncology
By Age group
- 0-5 Years
- 5-10 Years
- 10-15 Years
By End User
- Hospitals
- Ambulatory surgery centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Integra LifeSciences Holdings
- B.Braun SE
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- LivaNova PLC
- Natus Medical Incorporated
- Abbott Laboratories
- KARL STORZ SE & Co. KG
- Zimmer Biomet Holding Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. Moderate intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of neurological disorders in children
3.4.1.2. Increase in government funding to support development activities for invention of new medical devices
3.4.1.3. Changing lifestyles led by growing industrialization and urbanization
3.4.2. Restraints
3.4.2.1. High cost associated with diagnosis and treatment monitoring of neurological disorders
3.4.3. Opportunities
3.4.3.1. Rise in awareness regarding the benefits of pediatric neurology devices
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: PEDIATRIC NEUROLOGY DEVICE MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Neurostimulation Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Neurosurgery Devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Interventional Neurology Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Cerebrospinal Fluid Management Devices
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: PEDIATRIC NEUROLOGY DEVICE MARKET, BY CONDITION
5.1. Overview
5.1.1. Market size and forecast
5.2. Stroke
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Seizures
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Hydrocephalus
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Oncology
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: PEDIATRIC NEUROLOGY DEVICE MARKET, BY AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. 0-5 Years
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. 5-10 Years
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. 10-15 Years
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: PEDIATRIC NEUROLOGY DEVICE MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Ambulatory surgery centers
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: PEDIATRIC NEUROLOGY DEVICE MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Product Type
8.2.3. Market size and forecast, by Condition
8.2.4. Market size and forecast, by Age group
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Product Type
8.2.6.1.3. Market size and forecast, by Condition
8.2.6.1.4. Market size and forecast, by Age group
8.2.6.1.5. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Product Type
8.2.6.2.3. Market size and forecast, by Condition
8.2.6.2.4. Market size and forecast, by Age group
8.2.6.2.5. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Product Type
8.2.6.3.3. Market size and forecast, by Condition
8.2.6.3.4. Market size and forecast, by Age group
8.2.6.3.5. Market size and forecast, by End User
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Product Type
8.3.3. Market size and forecast, by Condition
8.3.4. Market size and forecast, by Age group
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Product Type
8.3.6.1.3. Market size and forecast, by Condition
8.3.6.1.4. Market size and forecast, by Age group
8.3.6.1.5. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Product Type
8.3.6.2.3. Market size and forecast, by Condition
8.3.6.2.4. Market size and forecast, by Age group
8.3.6.2.5. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Product Type
8.3.6.3.3. Market size and forecast, by Condition
8.3.6.3.4. Market size and forecast, by Age group
8.3.6.3.5. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Product Type
8.3.6.4.3. Market size and forecast, by Condition
8.3.6.4.4. Market size and forecast, by Age group
8.3.6.4.5. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Product Type
8.3.6.5.3. Market size and forecast, by Condition
8.3.6.5.4. Market size and forecast, by Age group
8.3.6.5.5. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Product Type
8.3.6.6.3. Market size and forecast, by Condition
8.3.6.6.4. Market size and forecast, by Age group
8.3.6.6.5. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Product Type
8.4.3. Market size and forecast, by Condition
8.4.4. Market size and forecast, by Age group
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. China
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Product Type
8.4.6.1.3. Market size and forecast, by Condition
8.4.6.1.4. Market size and forecast, by Age group
8.4.6.1.5. Market size and forecast, by End User
8.4.6.2. Japan
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Product Type
8.4.6.2.3. Market size and forecast, by Condition
8.4.6.2.4. Market size and forecast, by Age group
8.4.6.2.5. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Product Type
8.4.6.3.3. Market size and forecast, by Condition
8.4.6.3.4. Market size and forecast, by Age group
8.4.6.3.5. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Product Type
8.4.6.4.3. Market size and forecast, by Condition
8.4.6.4.4. Market size and forecast, by Age group
8.4.6.4.5. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Product Type
8.4.6.5.3. Market size and forecast, by Condition
8.4.6.5.4. Market size and forecast, by Age group
8.4.6.5.5. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Product Type
8.4.6.6.3. Market size and forecast, by Condition
8.4.6.6.4. Market size and forecast, by Age group
8.4.6.6.5. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Product Type
8.5.3. Market size and forecast, by Condition
8.5.4. Market size and forecast, by Age group
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Product Type
8.5.6.1.3. Market size and forecast, by Condition
8.5.6.1.4. Market size and forecast, by Age group
8.5.6.1.5. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Product Type
8.5.6.2.3. Market size and forecast, by Condition
8.5.6.2.4. Market size and forecast, by Age group
8.5.6.2.5. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Product Type
8.5.6.3.3. Market size and forecast, by Condition
8.5.6.3.4. Market size and forecast, by Age group
8.5.6.3.5. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Product Type
8.5.6.4.3. Market size and forecast, by Condition
8.5.6.4.4. Market size and forecast, by Age group
8.5.6.4.5. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. Integra LifeSciences Holdings
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. B.Braun SE
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.3. Medtronic plc
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.3.7. Key strategic moves and developments
10.4. Natus Medical Incorporated
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.4.7. Key strategic moves and developments
10.5. Stryker Corporation
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. Boston Scientific Corporation
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. Abbott Laboratories
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Business performance
10.7.7. Key strategic moves and developments
10.8. LivaNova PLC
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Zimmer Biomet Holding Inc.
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. KARL STORZ SE & Co. KG
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
List of Tables
Table 01. Global Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 02. Pediatric Neurology Device Market for Neurostimulation Devices, by Region, 2021-2031 (Revenue, $Million)
Table 03. Pediatric Neurology Device Market for Neurosurgery Devices, by Region, 2021-2031 (Revenue, $Million)
Table 04. Pediatric Neurology Device Market for Interventional Neurology Devices, by Region, 2021-2031 (Revenue, $Million)
Table 05. Pediatric Neurology Device Market for Cerebrospinal Fluid Management Devices, by Region, 2021-2031 (Revenue, $Million)
Table 06. Pediatric Neurology Device Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 07. Global Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 08. Pediatric Neurology Device Market for Stroke, by Region, 2021-2031 (Revenue, $Million)
Table 09. Pediatric Neurology Device Market for Seizures, by Region, 2021-2031 (Revenue, $Million)
Table 10. Pediatric Neurology Device Market for Hydrocephalus, by Region, 2021-2031 (Revenue, $Million)
Table 11. Pediatric Neurology Device Market for Oncology, by Region, 2021-2031 (Revenue, $Million)
Table 12. Pediatric Neurology Device Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 13. Global Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 14. Pediatric Neurology Device Market for 0-5 Years, by Region, 2021-2031 (Revenue, $Million)
Table 15. Pediatric Neurology Device Market for 5-10 Years, by Region, 2021-2031 (Revenue, $Million)
Table 16. Pediatric Neurology Device Market for 10-15 Years, by Region, 2021-2031 (Revenue, $Million)
Table 17. Global Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 18. Pediatric Neurology Device Market for Hospitals, by Region, 2021-2031 (Revenue, $Million)
Table 19. Pediatric Neurology Device Market for Ambulatory Surgery Centers, by Region, 2021-2031 (Revenue, $Million)
Table 20. Pediatric Neurology Device Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 21. Pediatric Neurology Device Market, by Region, 2021-2031 (Revenue, $Million)
Table 22. North America Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 23. North America Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 24. North America Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 25. North America Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 26. North America Pediatric Neurology Device Market, by Country, 2021-2031 (Revenue, $Million)
Table 27. U.S. Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 28. U.S. Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 29. U.S. Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 30. U.S. Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 31. Canada Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 32. Canada Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 33. Canada Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 34. Canada Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 35. Mexico Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 36. Mexico Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 37. Mexico Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 38. Mexico Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 39. Europe Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 40. Europe Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 41. Europe Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 42. Europe Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 43. Europe Pediatric Neurology Device Market, by Country, 2021-2031 (Revenue, $Million)
Table 44. Germany Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 45. Germany Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 46. Germany Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 47. Germany Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 48. France Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 49. France Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 50. France Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 51. France Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 52. UK Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 53. UK Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 54. UK Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 55. UK Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 56. Italy Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 57. Italy Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 58. Italy Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 59. Italy Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 60. Spain Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 61. Spain Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 62. Spain Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 63. Spain Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 64. Rest of Europe Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 65. Rest of Europe Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 66. Rest of Europe Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 67. Rest of Europe Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 68. Asia-Pacific Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 69. Asia-Pacific Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 70. Asia-Pacific Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 71. Asia-Pacific Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 72. Asia-Pacific Pediatric Neurology Device Market, by Country, 2021-2031 (Revenue, $Million)
Table 73. China Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 74. China Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 75. China Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 76. China Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 77. Japan Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 78. Japan Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 79. Japan Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 80. Japan Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 81. India Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 82. India Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 83. India Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 84. India Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 85. Australia Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 86. Australia Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 87. Australia Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 88. Australia Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 89. South Korea Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 90. South Korea Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 91. South Korea Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 92. South Korea Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 93. Rest of Asia-Pacific Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 94. Rest of Asia-Pacific Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 95. Rest of Asia-Pacific Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 96. Rest of Asia-Pacific Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 97. LAMEA Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 98. LAMEA Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 99. LAMEA Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 100. LAMEA Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 101. LAMEA Pediatric Neurology Device Market, by Country, 2021-2031 (Revenue, $Million)
Table 102. Brazil Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 103. Brazil Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 104. Brazil Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 105. Brazil Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 106. Saudi Arabia Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 107. Saudi Arabia Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 108. Saudi Arabia Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 109. Saudi Arabia Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 110. South Africa Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 111. South Africa Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 112. South Africa Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 113. South Africa Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 114. Rest of LAMEA Pediatric Neurology Device Market, by Product Type, 2021-2031 (Revenue, $Million)
Table 115. Rest of LAMEA Pediatric Neurology Device Market, by Condition, 2021-2031 (Revenue, $Million)
Table 116. Rest of LAMEA Pediatric Neurology Device Market, by Age Group, 2021-2031 (Revenue, $Million)
Table 117. Rest of LAMEA Pediatric Neurology Device Market, by End-user, 2021-2031 (Revenue, $Million)
Table 118. Integra Lifesciences Holdings: Key Executives
Table 119. Integra Lifesciences Holdings: Company Snapshot
Table 120. Integra Lifesciences Holdings: Product Segments
Table 121. Integra Lifesciences Holdings: Product Portfolio
Table 122. Integra Lifesciences Holdings: Key Strategies
Table 123. B.Braun SE: Key Executives
Table 124. B.Braun SE: Company Snapshot
Table 125. B.Braun SE: Product Segments
Table 126. B.Braun SE: Product Portfolio
Table 127. Medtronic PLC: Key Executives
Table 128. Medtronic PLC: Company Snapshot
Table 129. Medtronic PLC: Product Segments
Table 130. Medtronic PLC: Product Portfolio
Table 131. Medtronic PLC: Key Strategies
Table 132. Natus Medical Incorporated: Key Executives
Table 133. Natus Medical Incorporated: Company Snapshot
Table 134. Natus Medical Incorporated: Product Segments
Table 135. Natus Medical Incorporated: Product Portfolio
Table 136. Natus Medical Incorporated: Key Strategies
Table 137. Stryker Corporation: Key Executives
Table 138. Stryker Corporation: Company Snapshot
Table 139. Stryker Corporation: Product Segments
Table 140. Stryker Corporation: Product Portfolio
Table 141. Boston Scientific Corporation: Key Executives
Table 142. Boston Scientific Corporation: Company Snapshot
Table 143. Boston Scientific Corporation: Product Segments
Table 144. Boston Scientific Corporation: Product Portfolio
Table 145. Abbott Laboratories: Key Executives
Table 146. Abbott Laboratories: Company Snapshot
Table 147. Abbott Laboratories: Product Segments
Table 148. Abbott Laboratories: Product Portfolio
Table 149. Abbott Laboratories: Key Strategies
Table 150. Livanova PLC: Key Executives
Table 151. Livanova PLC: Company Snapshot
Table 152. Livanova PLC: Product Segments
Table 153. Livanova PLC: Product Portfolio
Table 154. Livanova PLC: Key Strategies
Table 155. Zimmer Biomet Holding Inc.: Key Executives
Table 156. Zimmer Biomet Holding Inc.: Company Snapshot
Table 157. Zimmer Biomet Holding Inc.: Product Segments
Table 158. Zimmer Biomet Holding Inc.: Product Portfolio
Table 159. Zimmer Biomet Holding Inc.: Key Strategies
Table 160. Karl Storz SE & Co. KG: Key Executives
Table 161. Karl Storz SE & Co. KG: Company Snapshot
Table 162. Karl Storz SE & Co. KG: Product Segments
Table 163. Karl Storz SE & Co. KG: Product Portfolio
List of Figures
Figure 01. Pediatric Neurology Device Market, 2021-2031
Figure 02. Segmentation of Pediatric Neurology Device Market, 2021-2031
Figure 03. Top Investment Pockets in Pediatric Neurology Device Market (2022-2031)
Figure 04. Moderate Bargaining Power of Suppliers
Figure 05. Moderate Bargaining Power of Buyers
Figure 06. Moderate Threat of Substitutes
Figure 07. Moderate Threat of New Entrants
Figure 08. Moderate Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globalpediatric Neurology Device Market
Figure 10. Pediatric Neurology Device Market, by Product Type, 2021(%)
Figure 11. Comparative Share Analysis of Pediatric Neurology Device Market for Neurostimulation Devices, by Country 2021-2031(%)
Figure 12. Comparative Share Analysis of Pediatric Neurology Device Market for Neurosurgery Devices, by Country 2021-2031(%)
Figure 13. Comparative Share Analysis of Pediatric Neurology Device Market for Interventional Neurology Devices, by Country 2021-2031(%)
Figure 14. Comparative Share Analysis of Pediatric Neurology Device Market for Cerebrospinal Fluid Management Devices, by Country 2021-2031(%)
Figure 15. Comparative Share Analysis of Pediatric Neurology Device Market for Others, by Country 2021-2031(%)
Figure 16. Pediatric Neurology Device Market, by Condition, 2021(%)
Figure 17. Comparative Share Analysis of Pediatric Neurology Device Market for Stroke, by Country 2021-2031(%)
Figure 18. Comparative Share Analysis of Pediatric Neurology Device Market for Seizures, by Country 2021-2031(%)
Figure 19. Comparative Share Analysis of Pediatric Neurology Device Market for Hydrocephalus, by Country 2021-2031(%)
Figure 20. Comparative Share Analysis of Pediatric Neurology Device Market for Oncology, by Country 2021-2031(%)
Figure 21. Comparative Share Analysis of Pediatric Neurology Device Market for Others, by Country 2021-2031(%)
Figure 22. Pediatric Neurology Device Market, by Age Group, 2021(%)
Figure 23. Comparative Share Analysis of Pediatric Neurology Device Market for 0-5 Years, by Country 2021-2031(%)
Figure 24. Comparative Share Analysis of Pediatric Neurology Device Market for 5-10 Years, by Country 2021-2031(%)
Figure 25. Comparative Share Analysis of Pediatric Neurology Device Market for 10-15 Years, by Country 2021-2031(%)
Figure 26. Pediatric Neurology Device Market, by End-user, 2021(%)
Figure 27. Comparative Share Analysis of Pediatric Neurology Device Market for Hospitals, by Country 2021-2031(%)
Figure 28. Comparative Share Analysis of Pediatric Neurology Device Market for Ambulatory Surgery Centers, by Country 2021-2031(%)
Figure 29. Comparative Share Analysis of Pediatric Neurology Device Market for Others, by Country 2021-2031(%)
Figure 30. Pediatric Neurology Device Market by Region, 2021
Figure 31. U.S. Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 32. Canada Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 33. Mexico Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 34. Germany Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 35. France Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 36. UK Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 37. Italy Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 38. Spain Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 39. Rest of Europe Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 40. China Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 41. Japan Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 42. India Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 43. Australia Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 44. South Korea Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 45. Rest of Asia-Pacific Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 46. Brazil Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 47. Saudi Arabia Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 48. South Africa Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 49. Rest of LAMEA Pediatric Neurology Device Market, 2021-2031 ($Million)
Figure 50. Top Winning Strategies, by Year
Figure 51. Top Winning Strategies, by Development
Figure 52. Top Winning Strategies, by Company
Figure 53. Product Mapping of Top 10 Players
Figure 54. Competitive Dashboard
Figure 55. Competitive Heatmap: Pediatric Neurology Device Market
Figure 56. Top Player Positioning, 2021
Figure 57. Integra Lifesciences Holdings: Net Revenue, 2019-2021 ($Million)
Figure 58. Integra Lifesciences Holdings: Research & Development Expenditure, 2019-2021
Figure 59. Integra Lifesciences Holdings: Revenue Share by Region, 2021 (%)
Figure 60. Integra Lifesciences Holdings: Revenue Share by Segment, 2021 (%)
Figure 61. B.Braun SE: Net Sales, 2019-2021 ($Million)
Figure 62. B.Braun SE: Revenue Share by Segment, 2021 (%)
Figure 63. B.Braun SE: Revenue Share by Region, 2021 (%)
Figure 64. Medtronic PLC: Net Sales, 2020-2022 ($Million)
Figure 65. Medtronic PLC: Revenue Share by Segment, 2022 (%)
Figure 66. Medtronic PLC: Revenue Share by Region, 2022 (%)
Figure 67. Natus Medical Incorporated: Net Revenue, 2019-2021 ($Million)
Figure 68. Natus Medical Incorporated: Revenue Share by Segment, 2021 (%)
Figure 69. Natus Medical Incorporated: Revenue Share by Region, 2021 (%)
Figure 70. Stryker Corporation: Net Revenue, 2019-2021 ($Million)
Figure 71. Stryker Corporation: Revenue Share by Segment, 2021 (%)
Figure 72. Stryker Corporation: Revenue Share by Region, 2021 (%)
Figure 73. Boston Scientific Corporation: Net Sales, 2019-2021 ($Million)
Figure 74. Boston Scientific Corporation: Revenue Share by Segment, 2021 (%)
Figure 75. Boston Scientific Corporation: Revenue Share by Region, 2021 (%)
Figure 76. Abbott Laboratories: Net Sales, 2019-2021 ($Million)
Figure 77. Abbott Laboratories: Revenue Share by Segment, 2021 (%)
Figure 78. Abbott Laboratories: Revenue Share by Region, 2021 (%)
Figure 79. Livanova PLC: Net Revenue, 2019-2021 ($Million)
Figure 80. Livanova PLC: Revenue Share by Segment, 2021 (%)
Figure 81. Livanova PLC: Revenue Share by Region, 2021 (%)
Figure 82. Zimmer Biomet Holding Inc.: Net Sales, 2019-2021 ($Million)
Figure 83. Zimmer Biomet Holding Inc.: Revenue Share by Region, 2021 (%)
Figure 84. Zimmer Biomet Holding Inc.: Revenue Share by Segment, 2021 (%)
Executive Summary
According to the report titled, 'Pediatric Neurology Device Market,' the pediatric neurology device market was valued at $2.8 billion in 2021, and is estimated to reach $5.8 billion by 2031, growing at a CAGR of 7.8% from 2022 to 2031.There are various neurological disorders which affects the pediatric population. Children are either born with the disorder, such as spina bifida and hydrocephalus or they acquire the disorder later in life like the result of a traumatic injury or serious infection. Neurological disorders are treated by specialists with the help of the specialized neurology devices. Pediatric neurology refers to a specialized branch of medicine that deals with the diagnosis and management of neurological conditions in pediatric population.
Key factors driving the growth of the pediatric neurology devices market include increase in prevalence of neurological disorders among the pediatric population, rise in the expenditure on the product development by the government & private organizations and large medical technology firms all over the world are increasingly focusing on acquiring companies that provide devices for neurological disease, which is expected to notably contribute toward the market growth. For instance, in July 2022, France-based investment firm ArchiMed has completed the acquisition of US-based neurodiagnostic devices provider Natus Medical for a total consideration of $1.2 billion. Moreover, increase in significant applications of neurological devices in pediatric patients, various initiatives & funding from government & private bodies for large-scale pediatric neurological diseases study projects thereby boosting the growth of market. However, the high cost of the devices used for the treatment of pediatric neurology is expected to hinder the growth of this market. Conversely, the number of R&D investments by companies is expected to create lucrative opportunities for the market.
The market also offers growth opportunities to the key players in the market. The target population is in tremendous need of the devices in the region like Europe and Asia-Pacific. Hence, challenges to cater the unmet needs of the target population provides the growth opportunities.
The pediatric neurology devices market is segmented based on product type, condition, age group, end user and region. On the basis of product type, the market is categorized into neurostimulator devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid (CSF) management devices and others. On the basis of condition, the market is classified into stroke, seizures, hydrocephalus, oncology and others. On the basis of age group, the market is classified into 0-5 years, 5-10 years, 10-15 years. On the basis of end user, the market is classified into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The key players profiled in the study include Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings KARL STORZ SE & Co. KG., LivaNova PLC, Medtronic plc, Natus Medical Incorporated (ArchiMed), Stryker Corporation, Zimmer Biomet. The players in the market have been actively engaged in the adoption various Strategies such as product approval, product launch, acquisition and partnership to remain competitive and gain advantage over the competitors in the market. For instance, in July 2022, Natus Medical Incorporated announced that the MED Platform II fund of ArchiMed completed the acquisition of Natus. In accordance with the definitive merger agreement, Natus shareholders received $33.50 in cash for each share of Natus common stock.
Key Market Insights
By product type, the cerebrospinal fluid management devices segment is the highest revenue contributor to the market and estimated to continue this during the analysis period, with a CAGR of 7.5%. However, the neurosurgery devices segment is estimated to be the fastest-growing segment with a CAGR of 8.7% during the forecast period.Based on condition, the seizures segment was the highest revenue contributor to the market with a CAGR of 7.9% during the forecast period. However, the stroke segment is estimated to be the fastest-growing segment with a CAGR of 8.7% during the forecast period.
Based on age group, the 5-10 years segment was the highest revenue contributor to the market with a CAGR of 7.9% during the forecast period. However, the 0-5 years segment is estimated to be the fastest-growing segment with a CAGR of 8.2% during the forecast period.
Based on end user, the hospitals segment was the highest revenue contributor to the market with a CAGR of 8.0% during the forecast period. However, the ambulatory surgery centers segment is estimated to be the fastest-growing segment with a CAGR of 8.4% during the forecast period.
Based on region, North America garnered the largest revenue share in 2021. However, the Asia-Pacific is estimated to be the fastest-growing segment with a CAGR of 9.2% during the forecast period.
Companies Mentioned
- Integra LifeSciences Holdings
- B.Braun SE
- Medtronic plc
- Stryker Corporation
- Boston Scientific Corporation
- LivaNova PLC
- Natus Medical Incorporated
- Abbott Laboratories
- KARL STORZ SE & Co. KG
- Zimmer Biomet Holding Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 220 |
| Published | January 2023 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 2764.9 million |
| Forecasted Market Value ( USD | $ 5842.62 million |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
